Europe 1 with AFP 12:07 p.m., February 23, 2022
The French pharmaceutical giant Sanofi announced Wednesday large-scale positive results for its anti-Covid vaccine, developed with the British GSK, a project which thus ends almost a year late following multiple postponements.
The French pharmaceutical giant Sanofi announced Wednesday large-scale positive results for its anti-Covid vaccine, developed with the British GSK, a project which thus ends almost a year late following multiple postponements.
"Sanofi and GSK will seek regulatory approval for their vaccine against (the) Covid-19" in the United States and in the European Union, the two groups announced in a press release, announcing that this vaccine had, in the term of these trials, shown to be effective in avoiding any hospitalization linked to Covid-19.
>> More information to follow...